In situ tissue regeneration through host stem cell recruitment

Experimental and Molecular Medicine

Volumn 45, Issue 11, 2013, Pages

  Ko, In Kap ^a   Lee, Sang Jin ^a   Atala, Anthony ^a   Yoo, James J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bioactive molecules; Biomaterials; In situ tissue regeneration; Protein delivery system; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL; CHEMOKINE RECEPTOR CCR4; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN; POLYESTER; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; STROMAL CELL DERIVED FACTOR 1ALPHA; SUBSTANCE P; TISSUE SCAFFOLD;

BONE REGENERATION; CARTILAGE; EX VIVO STUDY; HOST CELL; HUMAN; IN SITU TISSUE REGENERATION; MICROENVIRONMENT; NONHUMAN; REGENERATIVE ABILITY; REVIEW; SKELETAL MUSCLE; STEM CELL; STEM CELL MOBILIZATION; TISSUE REGENERATION; ANIMAL; CYTOLOGY; METABOLISM; METHODOLOGY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; PROCEDURES; TISSUE SCAFFOLD;

ANIMALS; GUIDED TISSUE REGENERATION; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84896567022     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.118     Document Type: Review

References (115)

1. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3: 192-195.
2. Grogan BF, Hsu Jr. Volumetric muscle loss. J Am Acad Orthop Surg 2011; 19 (Suppl. 1), S35-S37.
3. Atala A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 2007; 1: 83-96.
4. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature 2009; 462: 433-441.
5. Green EM, Lee RT. Proteins and small molecules for cellular regenerative medicine. Physiol Rev 2013; 93: 311-325.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
7. Bartsch G, Yoo JJ, De Coppi P, Siddiqui MM, Schuch G, Pohl HG et al. Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev 2005; 14: 337-348.
8. De Ugarte DA, Ashjian PH, Elbarbary A, Hedrick MH. Future of fat as raw material for tissue regeneration. Ann Plast Surg 2003; 50: 215-219.
9. Deasy BM, Huard J. Gene therapy and tissue engineering based on muscle-derived stem cells. Curr Opin Mol Ther 2002; 4: 382-389.
10. Gage FH. Mammalian neural stem cells. Science 2000; 287: 1433-1438.
11. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005; 97: 52-61.
12. Zhang Y, Bai XF, Huang CX. Hepatic stem cells: Existence and origin. World J Gastroenterol 2003; 9: 201-204.
13. Dahlberg A, Delaney C, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 2011; 117: 6083-6090.
14. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213: 341-347.
15. Caplan AI, Correa D. The MSC: An injury drugstore. Cell Stem Cell 2011; 9: 11-15.
16. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
17. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 2008; 14: 1835-1842.
18. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
19. Lee SJ, Van Dyke M, Atala A, Yoo JJ. Host cell mobilization for in situ tissue regeneration. Rejuvenation Res 2008; 11: 747-756.
20. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23: 47-55.
21. Lee KY, Jeong L, Kang YO, Lee SJ, Park WH. Electrospinning of polysaccharides for regenerative medicine. Adv Drug Deliv Rev 2009; 61: 1020-1032.
22. Cen L, Liu W, Cui L, Zhang W, Cao Y. Collagen tissue engineering: Development of novel biomaterials and applications. Pediatr Res 2008; 63: 492-496.
23. Cavallaro JF, Kemp PD, Kraus KH. Collagen fabrics as biomaterials. Biotechnol Bioeng 1994; 44: 146.
24. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980; 14: 65-81.
25. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980; 14: 107-132.
26. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010; 16: 927-933.
27. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14: 213-221.
28. Badylak SF. Regenerative medicine and developmental biology: The role of the extracellular matrix. Anat Rec B New Anat 2005; 287: 36-41.
29. Gilding D. Biodegradable polymers. In: Williams D (ed Biocompatibility of Clinical Implant Materials. CRC Press: Boca Raton, FL, 1981: 209-232.
30. Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 1994; 12: 689-693.
31. Mikos AG, Lyman MD, Freed LE, Langer R. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994; 15: 55-58.
32. Han D, Gouma PI. Electrospun bioscaffolds that mimic the topology of extracellular matrix. Nanomedicine 2006; 2: 37-41.
33. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998; 42: 396-402.
34. Lee SJ, Liu J, Oh SH, Soker S, Atala A, Yoo JJ. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008; 29: 2891-2898.
35. Lee SJ, Oh SH, Liu J, Soker S, Atala A, Yoo JJ. The use of thermal treatments to enhance the mechanical properties of electrospun poly (epsilon-caprolactone) scaffolds. Biomaterials 2008; 29: 1422-1430.
36. Choi JS, Lee SJ, Christ GJ, Atala A, Yoo JJ. The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-Aligned skeletal muscle myotubes. Biomaterials 2008; 29: 2899-2906.
37. Peppas NA, Langer R. New challenges in biomaterials. Science 1994; 263: 1715-1720.
38. Hong HS, Lee J, Lee E, Kwon YS, Ahn W, Jiang MH et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med 2009; 15: 425-435.
39. Hong HS, Kim do Y, Yoon KJ, Son Y. A new paradigm for stem cell therapy: Substance-P as a stem cell-stimulating agent. Arch Pharm Res 2011; 34: 2003-2006.
40. Amadesi S, Reni C, Katare R, Meloni M, Oikawa A, Beltrami AP et al. Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects. Circulation 2012; 125: 1774-1786. S1-19.
41. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-120.
42. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-694.
43. Zhou M, Liu Z, Li K, Qiao W, Jiang X, Ran F et al. Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft. J Biomed Mater Res A. 2010; 95: 600-610.
44. Liang Y, Jensen TW, Roy EJ, Cha C, Devolder RJ, Kohman RE et al. Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization. Biomaterials 2011; 32: 2004-2012.
45. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201: 1307-1318.
46. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 2010; 107: 11008-11013.
47. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 2006; 108: 2438-2445.
48. McNiece IK, Briddell RA. Stem cell factor. J Leukoc Biol 1995; 58: 14-22.
49. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009; 4: 62-72.
50. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846.
51. Vanden Berg-Foels WS. In situ tissue regeneration: Chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev (doi:10.1089/ ten.teb.2013.0100).
52. Lau TT, Wang DA. Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine. Expert Opin Biol Ther 2011; 11: 189-197.
53. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-567.
54. Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010; 31: 3997-4008.
55. Lim TC, Rokkappanavar S, Toh WS, Wang LS, Kurisawa M, Spector M. Chemotactic recruitment of adult neural progenitor cells into multifunctional hydrogels providing sustained SDF-1alpha release and compatible structural support. FASEB J. 2013; 27: 1023-1033.
56. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007; 116: 1683-1692.
57. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009; 4: 313-323.
58. Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007; 25: 245-251.
59. Martinez CO, McHale MJ, Wells JT, Ochoa O, Michalek JE, McManus LM et al. Regulation of skeletal muscle regeneration by CCR2-Activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol 2010; 299: R832-R842.
60. Louridas M, Letourneau S, Lautatzis ME, Vrontakis M. Galanin is highly expressed in bone marrow mesenchymal stem cells and facilitates migration of cells both in vitro and in vivo. Biochem Biophys Res Commun 2009; 390: 867-871.
61. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-1034.
62. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010; 31: 6279-6308.
63. Elia R, Fuegy PW, VanDelden A, Firpo MA, Prestwich GD, Peattie RA. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials 2010; 31: 4630-4638.
64. Ko IK, Ju YM, Chen T, Atala A, Yoo JJ, Lee SJ. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J. 2012; 26: 158-168.
65. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol 2005; 94: 1-22.
66. Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-Tissue augmentation implant material. J Am Acad Dermatol 1997; 36: 544-549.
67. Jarcho M, Kay JF, Gumaer KI, Doremus RH, HP Drobeck. Tissue, cellular and subcellular events at a bone-ceramic hydroxylapatite interface. J Bioeng 1977; 1: 79-92.
68. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: A review. J Control Release 2006; 113: 102-110.
69. Jansen JA, Vehof JW, Ruhe PQ, Kroeze-Deutman H, Kuboki Y, Takita H et al. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005; 101: 127-136.
70. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005; 16: 329-345.
71. Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 2001; 18: 1600-1606.
72. Barnes B, Boden SD, Louis-Ugbo J, Tomak PR, Park JS, Park MS et al. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine (Phila Pa 1976). 2005; 30: 1127-1133.
73. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976). 2002; 27: 2396-2408.
74. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999; 81: 710-718.
75. Erggelet C, Endres M, Neumann K, Morawietz L, Ringe J, Haberstroh K et al. Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J Orthop Res 2009; 27: 1353-1360.
76. Lee CH, Cook JL, Mendelson A, Moioli EK, Yao H, Mao JJ. Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. Lancet 2010; 376: 440-448.
77. Huard J, Li Y, Fu FH. Muscle injuries and repair: Current trends in research. J Bone Joint Surg Am 2002; 84-A(5: 822-832.
78. Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008; 456: 502-506.
79. Le Grand F, Rudnicki MA. Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol 2007; 19: 628-633.
80. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R et al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 2002; 157: 851-864.
81. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
82. Sun D, Martinez CO, Ochoa O, Ruiz-Willhite L, Bonilla JR, Centonze VE et al. Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J. 2009; 23: 382-395.
83. Polesskaya A, Seale P, Rudnicki MA. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003; 113: 841-852.
84. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002; 111: 589-601.
85. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009; 20: 419-427.
86. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 2010; 107: 3287-3292.
87. Kin S, Hagiwara A, Nakase Y, Kuriu Y, Nakashima S, Yoshikawa T et al. Regeneration of skeletal muscle using in situ tissue engineering on an acellular collagen sponge scaffold in a rabbit model. ASAIO J. 2007; 53: 506-513.
88. Suzuki Y, Tanihara M, Suzuki K, Saitou A, Sufan W, Nishimura Y. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J Biomed Mater Res 2000; 50: 405-409.
89. Woodruff MA, Rath SN, Susanto E, Haupt LM, Hutmacher DW, Nurcombe V et al. Sustained release and osteogenic potential of heparan sulfatedoped fibrin glue scaffolds within a rat cranial model. J Mol Histol 2007; 38: 425-433.
90. Kodama N, Nagata M, Tabata Y, Ozeki M, Ninomiya T, Takagi R. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. Bone 2009; 44: 699-707.
91. Yamamoto M, Takahashi Y, Tabata Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2006; 12: 1305-1311.
92. Osathanon T, Linnes ML, Rajachar RM, Ratner BD, Somerman MJ, Giachelli CM. Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials 2008; 29: 4091-4099.
93. Haidar ZS, Hamdy RC, Tabrizian M. Biocompatibility and safety of a hybrid core-shell nanoparticulate OP-1 delivery system intramuscularly administered in rats. Biomaterials 2010; 31: 2746-2754.
94. Mabilleau G, Aguado E, Stancu IC, Cincu C, Basle MF, Chappard D. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture. Biomaterials 2008; 29: 1593-1600.
95. Erggelet C, Neumann K, Endres M, Haberstroh K, Sittinger M, Kaps C. Regeneration of ovine articular cartilage defects by cell-free polymerbased implants. Biomaterials 2007; 28: 5570-5580.
96. Kubo M, Imai S, Fujimiya M, Isoya E, Ando K, Mimura T et al. Exogenous collagen-enhanced recruitment of mesenchymal stem cells during rabbit articular cartilage repair. Acta Orthop 2007; 78: 845-855.
97. Matsumura G, Isayama N, Matsuda S, Taki K, Sakamoto Y, Ikada Y et al. Long-Term results of cell-free biodegradable scaffolds for in situ tissue engineering of pulmonary artery in a canine model. Biomaterials 2013; 34: 6422-6428.
98. Salimath AS, Phelps EA, Boopathy AV, Che PL, Brown M, Garcia AJ et al. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 2012; 7: E50980.
99. Zheng W, Wang Z, Song L, Zhao Q, Zhang J, Li D et al. Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials 2012; 33: 2880-2891.
100. De Visscher G, Mesure L, Meuris B, Ivanova A, Flameng W. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1alpha. Acta Biomater 2012; 8: 1330-1338.
101. Kuwabara F, Narita Y, Yamawaki-Ogata A, Kanie K, Kato R, Satake M et al. Novel small-caliber vascular grafts with trimeric peptide for acceleration of endothelialization. Ann Thorac Surg 2012; 93: 156-163; discussion 63.
102. Jordan JE, Williams JK, Lee SJ, Raghavan D, Atala A, Yoo JJ. Bioengineered self-seeding heart valves. J Thorac Cardiovasc Surg 2012; 143: 201-208.
103. Iwai S, Sawa Y, Taketani S, Torikai K, Hirakawa K, Matsuda H. Novel tissue-engineered biodegradable material for reconstruction of vascular wall. Ann Thorac Surg 2005; 80: 1821-1827.
104. Yokota T, Ichikawa H, Matsumiya G, Kuratani T, Sakaguchi T, Iwai S et al. In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding. J Thorac Cardiovasc Surg 2008; 136: 900-907.
105. Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999; 17: 1083-1086.
106. Fujimoto KL, Tobita K, Merryman WD, Guan J, Momoi N, Stolz DB et al. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol 2007; 49: 2292-2300.
107. Fujimoto KL, Guan J, Oshima H, Sakai T, Wagner WR. In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures. Ann Thorac Surg 2007; 83: 648-654.
108. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008; 117: 1388-1396.
109. Dahms SE, Piechota HJ, Dahiya R, Gleason CA, Hohenfellner M, Tanagho EA. Bladder acellular matrix graft in rats: Its neurophysiologic properties and mRNA expression of growth factors TGF-Alpha and TGF-beta. Neurourol Urodyn 1998; 17: 37-54.
110. Urita Y, Komuro H, Chen G, Shinya M, Kaneko S, Kaneko M et al. Regeneration of the esophagus using gastric acellular matrix: An experimental study in a rat model. Pediatr Surg Int 2007; 23: 21-26.
111. Boucard N, Viton C, Agay D, Mari E, Roger T, Chancerelle Y et al. The use of physical hydrogels of chitosan for skin regeneration following thirddegree burns. Biomaterials 2007; 28: 3478-3488.
112. Abbushi A, Endres M, Cabraja M, Kroppenstedt SN, Thomale UW, Sittinger M et al. Regeneration of intervertebral disc tissue by resorbable cell-free polyglycolic acid-based implants in a rabbit model of disc degeneration. Spine (Phila Pa 1976). 2008; 33: 1527-1532.
113. Hori Y, Nakamura T, Matsumoto K, Kurokawa Y, Satomi S, Shimizu Y. Experimental study on in situ tissue engineering of the stomach by an acellular collagen sponge scaffold graft. ASAIO J. 2001; 47: 206-210.
114. Nakahara T, Nakamura T, Kobayashi E, Inoue M, Shigeno K, Tabata Y et al. Novel approach to regeneration of periodontal tissues based on in situ tissue engineering: Effects of controlled release of basic fibroblast growth factor from a sandwich membrane. Tissue Eng 2003; 9: 153-162.
115. Herberg S, Siedler M, Pippig S, Schuetz A, Dony C, Kim CK et al. Development of an injectable composite as a carrier for growth factorenhanced periodontal regeneration. J Clin Periodontol 2008; 35: 976-984.